Home | About Us | Contact Us  
   
Home
Product Catalog
Getting Started
Tutorials
News
Customer Service
New Page
 
 DAWN AC Anticoagulation Software E-Newsletter
   November 2009 
 

 



Welcome
to the November edition of the DAWN AC
Anticoagulation Software E-Newsletter for 2009
.
 
 
 
 

DAWN List View Filters

 














Here is how the With/Without option works on DAWN list views:

The With/Without option appears to the left of your drop down list of custom filters and is set to “With” by default.  For example, if you have the “Scheduled Tests” filter selected on your Work List or Attendance list view the filter will read “With“ “Scheduled Tests”.   If you change the With/Without option to “Without” the filter will now read “Without” “Scheduled Tests” and display all records with a status other than “Scheduled”, for example, “Authorised” records or records with an INR and provisional dose.

Changing “With” to “Without” reverses the filter selected to its right (“Scheduled Tests” in this example).  It does not reverse all the other criteria selected on the page such as date, clinic or target range. In other words selecting “Without”  “Authorised Doses” and setting the date filter to “Today” finds all patients with treatment records for today that have not been authorised.  It does not find everybody with an authorised test on a date other than today.

Our preliminary enquiries show that few people use the “Without” option, so to avoid potential confusion we are proposing to remove this option in a future release.  Please reply to this email if you do use the “Without” option.

DAWN Version 7.9 Available Soon!



 
We plan to release the latest version of DAWN, version 7.9, in the next month or so. This version contains many new features and improvements, such as:

- An appearance 'face-lift', to improve the look and feel of the software
- A new patient wizard to make adding a new patient easier and more intuitive
- A simpler more intuitive treatment plan screen

- Clearer messages indicating reasons why when a user fails to log into DAWN
- An extra patient search option to search for a patient from any screen within DAWN
- Standardised transport/home visits scroll down options

For further details on version 7.9 please contact us at sales@4s-dawn.com 
 
 

Study Shows Voice Response System May Improve Patient Care

 
 
 
 
A study published in the Canadian Medical Association Journal has found that using an interactive voice response system may potentially improve the monitoring of anticoagulation patients.
 
The study, conducted at the Ottawa Hospital, looked at 226 patients over a period of a few months who had been on therapy for 3 months or more. 77.8% of all dosage instruction messages were given via the CallAssureCDM voice response system. It was found that the anticoagulation control was similar when compared to periods when the patients were not given information in this way, and the system reduced staff workload, giving a reduction of 33% of the time usually taken to personally call the patients.
 
Once the study was completed, 76.6% of patients then opted to continue with the voice response system. More studies are required at this point to conclusively demonstrate the voice response systems effectiveness.

To read more of this article, please follow the link below:

http://www.vocantas.com/documents/CMAJ_180.9.927.pdf
 
We currently have several sites who use the CallAssureCDM voice response system in conjunction with DAWN AC. To find out more information, please reply to this email.
 

Statins May Cut Chance of Fatal Blood Clots

 
A study presented at the annual conference of the American College of Physicians recently has found that the use of statins can reduce the risk of developing a clot in the lung or leg in high risk patients by two thirds.
 
The study looked at 593 patients suffering from atherosclerosis, 73% of whom were taking statins. It was found that patients not taking statins were three times more likely to develop a clot. It was also found that patients taking high-strength statins were at a lower risk than those on a normal strength.
 
Dr. Kalpalatha Guntupalli, president of the college, commented, "Although more research is needed, statins may prove effective in helping to reduce the incidence of (these clots) in specific patient populations".

To read more of this article, please follow the link below:

http://www.telegraph.co.uk/health/healthnews/6494760/Statins-can-prevent-potentially-fatal-blood-clots.html
 

 

Smoking and Obesity Increases Risk of Thromboembolisms

 
Researchers from the Copenhagen City Heart Study have found that smoking and a high BMI (body mass index) are major risk factors in patients who develop a venous thromboembolic event.

The researchers reviewed data from 18,954 patients and found that out of the 992 venous thrombotic events that were recorded, patients who smoked were at a higher risk, with the amount that the patient smoked relating to the risk level. Being overweight also increased the risk, with the body weight amount related to the risk level.

Dr. Holst, MD at the University Hospital Rigshospitalet in Copenhagen, commented, "We did not calculate whether being overweight and smoking increased the individual risk or was synergistic and increased risk greater. I think that is going to be my next project with this data -- to see how having more than one of the risk factors impacts venous thromboses."

To read more of this article, please follow the link below:

http://www.docguide.com/news/content.nsf/news
/852576140048867A85257673007C58EC
 

NEW DAWN Module for Haematology

 
DAWN Clinical Framework now has a module for managing patients with myeloproliferative disorders. It can track MPN, CLL and MGUS results as well as other relevant tests.
The tracking of appointments is easily handled by the DAWN Reminders and Lists views to ensure follow-up.

The DAWN trends and alerting engine scans all results for trends and abnormal results.

If you are interested in this module or know of anyone who is then please reply to this email.

 

 

 
 
Phone: +44 (0) 15395 63091